Project Grant R21HD117260
Award Date
9/19/24
Completion Date
8/31/26
Dollars Obligated
$466K
Federal Agency
National Institute of Child Health and Human Development
Federal Grant Program
93.865
Assistance Type
Project Grant
Place of Performance
New York, NY 10016, USA
Similar Awards
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $105,625.00 to fund research on a new therapy for neurodevelopmental mitochondrial disorders. The research aims to analyze how a specific succinyl-CoA precursor is metabolized in the brain of a mouse model of pyruvate dehydrogenase deficiency, a common mitochondrial disease, and to...
This Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) supports research to investigate the relationship between mitochondrial dysfunction and the impact of autism spectrum disorder (ASD)-related risk genes on neuronal structure and function. The $253,500 award, made on April 10, 2025, will allow the Icahn School of Medicine at Mount Sinai to establish...
This federal Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), provides $1,727,892 to support research on the role of the RASA1 gene in embryonic vascular and lymphatic development. The award aims to define the cellular and molecular effects of RASA1 deficiency that contribute to lymphatic defects, investigate how RASA1 mediates vascular regression and its link...
This Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), will provide $149,804 to Duke University to conduct research on understanding the role of mitochondrial specialization in early development. The key objectives of this research project are to test the hypotheses that unique mitochondrial electron transport chain (ETC) levels develop after tissue specification...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $596,937.00 to investigate the role of the FMRP protein in regulating mitochondrial function and energy metabolism in human neuron development. The research aims to elucidate the mechanisms by which FMRP and its target RACK1 regulate activity-dependent mitochondrial...
This Project Grant award, funded by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), aims to comprehensively investigate the intricate relationship between cellular metabolism and neurodevelopmental deficits observed in Down Syndrome (DS). The $2,010,230 award, spanning from July 2024 to April 2029, will utilize human stem cell and mouse models to characterize and modulate the...
This Project Grant awarded by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) aims to develop the first murine animal model and adeno-associated virus (AAV)-based gene therapy for mtatp6 mitochondrial diseases, which currently have no approved treatments. The $498,000 award provides funding from August 1, 2024 through June 30, 2027 to the University of Massachusetts Medical School (UMass...
This $1,538,070.00 federal Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), will support research to investigate the role of mitochondrial nutrient transport in regulating trophoblast differentiation. The project aims to use CRISPR-Cas9 genetic tools to manipulate the expression of the mitochondrial pyruvate carrier (MPC) and glutamine transporter (SLC1A5VAR) in...
This federal Project Grant award, valued at $431,750, was provided by the National Institute of Child Health and Human Development under the Child Health and Human Development Extramural Research program (CFDA 93.865). The grant supports research by Rutgers, The State University of New Jersey, to investigate the mechanistic impact of mutations in the mitochondrial Lon protease on mitochondrial DNA integrity and gene expression. The research employs patient-derived induced pluripotent stem...
This Project Grant award from the National Institutes of Health (NIH) under the Research Infrastructure Programs (CFDA 93.351) supports the development of innovative in vivo animal models for studying mitochondrial DNA (mtDNA) diseases. The $629,508 award to the University of Texas at Austin, effective September 16, 2024 through August 31, 2028, aims to generate designer zebrafish models with specific mtDNA variants to enable new research approaches for diagnosing and treating these complex...